Integrating valve-inspired design features into poly(ethylene glycol) hydrogel scaffolds for heart valve tissue engineering

Acta Biomaterialia

Volumn 14, Issue , 2015, Pages 11-21

  Zhang, Xing ^a   Xu, Bin ^a   Puperi, Daniel S ^a   Yonezawa, Aline L ^b   Wu, Yan ^c   Tseng, Hubert ^a   Cuchiara, Maude L ^c   West, Jennifer L ^c   Grande Allen, K Jane ^a  

^a Rice University   (United States)

^b University of Florida   (United States)

^c USA   (United States)

Author keywords

Anisotropy; Bioactivity; Heart valve tissue engineering; Hydrogel; Poly(ethylene glycol)

Indexed keywords

ANISOTROPY; BIOMECHANICS; BIOMIMETICS; ETHYLENE GLYCOL; HEART; PEPTIDES; POLYETHYLENE GLYCOLS; POLYOLS; SCAFFOLDS (BIOLOGY); TISSUE; VALVES (MECHANICAL);

ANISOTROPIC MECHANICAL PROPERTIES; BIOLOGICAL FUNCTIONS; DESIGN FEATURES; DIACRYLATES; EXTRACELLULAR MATRICES; HEART VALVE TISSUE ENGINEERINGS; HYDROGEL SCAFFOLDS; INTERSTITIALS; MECHANICAL BEHAVIOR; PHOTOLITHOGRAPHIC PATTERNING;

HYDROGELS;

ALPHA SMOOTH MUSCLE ACTIN; ARGINYLGLYCYLASPARTYLSERINE; BIOMIMETIC MATERIAL; CALDESMON; CALPONIN; CONTRACTILE PROTEIN; FIBRONECTIN; GELATINASE A; MACROGOL; MYOSIN HEAVY CHAIN; VIMENTIN; HYDROGEL; MACROGOL DERIVATIVE; PEPTIDE; POLY(ETHYLENE GLYCOL)DIACRYLATE;

ANIMAL CELL; ANIMAL TISSUE; ANISOTROPY; ARTICLE; BIOLOGICAL FUNCTIONS; CELL ACTIVATION; CELL ACTIVITY; CELL ADHESION; CELL COUNT; CELL GROWTH; CELL SIZE; CELL SPREADING; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS LINKING; DEGRADATION; EXTRACELLULAR MATRIX; FOLLOW UP; HEART VALVE REPLACEMENT; HYDROGEL; IN VITRO STUDY; MEMBRANE LEAFLET; MICROENVIRONMENT; MODULATION; MOUSE; MYOFIBROBLAST; NANOFABRICATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLD; ULTRAVIOLET RADIATION; ANIMAL; CELL CULTURE; CELL SHAPE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; HEART VALVE; HEART VALVE PROSTHESIS; IMMUNOHISTOCHEMISTRY; METABOLISM; PHARMACOLOGY; PIG; PROCEDURES; PROSTHESIS; TENSILE STRENGTH; YOUNG MODULUS;

ANIMALS; ANISOTROPY; CELL SHAPE; CELLS, CULTURED; ELASTIC MODULUS; EXTRACELLULAR MATRIX; HEART VALVE PROSTHESIS; HEART VALVES; HYDROGEL; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; PEPTIDES; POLYETHYLENE GLYCOLS; PROSTHESIS DESIGN; SUS SCROFA; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84921827692     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.11.042     Document Type: Article

References (67)

1. Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med 2005;2:60-1.
2. Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635-41.
3. Fann JI, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB, et al. Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg 1996;62:1301-11. discussion 1311-2.
4. Schoen FJ, Levy RJ. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 1999;47:439-65.
5. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005;79:1072-80.
6. Sacks MS, Schoen FJ, Mayer JE. Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng 2009;11:289-313.
7. Murphy SV, Atala A. Organ engineering - combining stem cells, biomaterials, and bioreactors to produce bioengineered organs for transplantation. BioEssays 2012;1-10.
8. Mol A, Smits AI, Bouten CV, Baaijens FP. Tissue engineering of heart valves: advances and current challenges. Expert Rev Med Devices 2009;6:259-75.
9. Apte SS, Paul A, Prakash S, Shum-Tim D. Current developments in the tissue engineering of autologous heart valves: moving towards clinical use. Future Cardiol 2011;7:77-97.
10. Shi Y, Iyer R, Soundararajan A, Dobkin D, Vesely I. Collagen-based tissue engineering as applied to heart valves. Conf Proc IEEE Eng Med Biol Soc 2005;5:4912-5.
11. Barsotti MC, Felice F, Balbarini A, Di Stefano R. Fibrin as a scaffold for cardiac tissue engineering. Biotechnol Appl Biochem 2011;58:301-10.
12. Ramamurthi A, Vesely I. Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials 2005;26:999-1010.
13. Stock UA, Mayer JE. Tissue engineering of cardiac valves on the basis of PGA/PLA Co-polymers. J Long Term Eff Med Implants 2001;11:249-60.
14. Del Gaudio C, Bianco A, Grigioni M. Electrospun bioresorbable trileaflet heart valve prosthesis for tissue engineering: in vitro functional assessment of a pulmonary cardiac valve design. Ann Ist Super Sanita 2008;44:178-86.
15. Weber B, Emmert MY, Behr L, Schoenauer R, Brokopp C, Drögemüller C, et al. Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation. Biomaterials 2012;33:4031-43.
16. Sauren AA, van Hout MC, van Steenhoven AA, Veldpaus FE, Janssen JD. The mechanical properties of porcine aortic valve tissues. J Biomech 1983;16:327-37.
17. Simionescu DT, Chen J, Jaeggli M, Wang B, Liao J. Form follows function: advances in trilayered structure replication for aortic heart valve tissue engineering. J Healthc Eng 2012;3:179-202.
18. Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng 2006;34:1799-819.
19. Brown RA, Phillips JB. Cell responses to biomimetic protein scaffolds used in tissue repair and engineering. Int Rev Cytol 2007;262:75-150.
20. Harris JM. Poly(ethylene glycol) chemistry: biotechnical and biomedical applications, vol. xxi. New York: Plenum Press; 1992. p. 385.
21. Zustiak SP, Leach JB. Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds with tunable degradation and mechanical properties. Biomacromolecules 2010;11:1348-57.
22. Truong V, Blakey I, Whittaker AK. Hydrophilic and amphiphilic polyethylene glycol-based hydrogels with tunable degradability prepared by "click" chemistry. Biomacromolecules 2012;13:4012-21.
23. Lee SH, Moon JJ, Miller JS, West JL. Poly(ethylene glycol) hydrogels conjugated with a collagenase-sensitive fluorogenic substrate to visualize collagenase activityduring three-dimensional cellmigration. Biomaterials2007;28:3163-70.
24. Lee HJ, Lee JS, Chansakul T, Yu C, Elisseeff JH, Yu SM. Collagen mimetic peptide-conjugated photopolymerizable PEG hydrogel. Biomaterials 2006;27:5268-76.
25. Benoit DS, Durney AR, Anseth KS. The effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation. Biomaterials 2007;28:66-77.
26. Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984;309:30-3.
27. Netzel-Arnett S, Fields GB, Birkedal-Hansen H, Van Wart HE. Sequence specificities of human fibroblast and neutrophil collagenases. J Biol Chem 1991;266:6747-55.
28. DeLong SA, Moon JJ, West JL. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials 2005;26:3227-34.
29. Hahn MS, Taite LJ, Moon JJ, Rowland MC, Ruffino KA, West JL. Photolithographic patterning of polyethylene glycol hydrogels. Biomaterials 2006;27:2519-24.
30. Bahney CS, Lujan TJ, Hsu CW, Bottlang M, West JL, Johnstone B. Visible light photoinitiation of mesenchymal stem cell-laden bioresponsive hydrogels. Eur Cell Mater 2011;22:43-55.
31. Saik JE, Gould DJ, Watkins EM, Dickinson ME, West JL. Covalently immobilized platelet-derived growth factor-BB promotes angiogenesis in biomimetic poly(ethylene glycol) hydrogels. Acta Biomater 2011;7:133-43.
32. Culver JC, Hoffmann JC, Poché RA, Slater JH, West JL, Dickinson ME. Three-dimensional biomimetic patterning in hydrogels to guide cellular organization. Adv Mater 2012;24:2344-8.
33. Stephens EH, Carroll JL, Grande-Allen KJ. The use of collagenase III for the isolation of porcine aortic valvular interstitial cells: rationale and optimization. J Heart Valve Dis 2007;16:175-83.
34. Nguyen QT, Hwang Y, Chen AC, Varghese S, Sah RL. Cartilage-like mechanical properties of poly(ethylene glycol)-diacrylate hydrogels. Biomaterials 2012;33:6682-90.
35. Drira Z, Yadavalli VK. Nanomechanical measurements of polyethylene glycol hydrogels using atomic force microscopy. J Mech Behav Biomed Mater 2013;18:20-8.
36. Durst CA, Cuchiara MP, Mansfield EG, West JL, Grande-Allen KJ. Flexural characterization of cell encapsulated PEGDA hydrogels with applications for tissue engineered heart valves. Acta Biomater 2011;7:2467-76.
37. Clark RE. Stress-strain characteristics of fresh and frozen human aortic and mitral leaflets and chordae tendineae. Implications for clinical use. J Thorac Cardiovasc Surg 1973;66(2):202-8.
38. Missirlis YF, Chong M. Aortic valve mechanics - Part I: Material properties of natural porcine aortic valves. J Bioeng 1978;2:287-300.
39. Lee JM, Boughner DR, Courtman DW. The glutaraldehyde-stabilized porcine aortic valve xenograft. II. Effect of fixation with or without pressure on the tensile viscoelastic properties of the leaflet material. J Biomed Mater Res 1984 Jan;18(1):79-98.
40. Stradins P, Lacis R, Ozolanta I, Purina B, Ose V, Feldmane L, et al. Comparison of biomechanical and structural properties between human aortic and pulmonary valve. Eur J Cardiothorac Surg 2004;26(3):634-9.
41. Taylor PM, Batten P, Brand NJ, Thomas PS, Yacoub MH. The cardiac valve interstitial cell. Int J Biochem Cell Biol 2003;35(2):113-8.
42. Thayer P, Balachandran K, Rathan S, Yap CH, Arjunon S, Jo H, et al. The effects of combined cyclic stretch and pressure on the aortic valve interstitial cell phenotype. Ann Biomed Eng 2011;39(6):1654-67.
43. Lutolf MP, Lauer-Fields JL, Schmoekel HG, Metters AT, Weber FE, Fields GB, et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci USA 2003;100:5413-8.
44. Moon JJ, Saik JE, Poché RA, Leslie-Barbick JE, Lee SH, Smith AA, et al. Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 2010;31:3840-7.
45. Benton JA, Fairbanks BD, Anseth KS. Characterization of valvular interstitial cell function in three dimensional matrix metalloproteinase degradable PEG hydrogels. Biomaterials 2009;30:6593-603.
46. Dreger SA, Taylor PM, Allen SP, Yacoub MH. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. J Heart Valve Dis 2002;11:875-80.
47. Schoen FJ. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 2008;118:1864-80.
48. Nguyen QT, Hwang Y, Chen AC, Varghese S, Sah RL. Cartilage-like mechanical properties of poly(ethylene glycol)-diacrylate hydrogels. Biomaterials 2012;33:6682-90.
49. Turturro MV, Sokic S, Larson JC, Papavasiliou G. Effective tuning of ligand incorporation and mechanical properties in visible light photopolymerized poly(ethylene glycol) diacrylate hydrogels dictates cell adhesion and proliferation. Biomed Mater 2013;8:025001.
50. Ashley GW, Henise J, Reid R, Santi DV. Hydrogel drug delivery system with predictable and tunable drug release and degradation rates. Proc Natl Acad Sci USA 2013;110:2318-23.
51. Courtney T, Sacks MS, Stankus J, Guan J, Wagner WR. Design and analysis of tissue engineering scaffolds that mimic soft tissue mechanical anisotropy. Biomaterials 2006;27:3631-8.
52. Masoumi N, Jean A, Zugates JT, Johnson KL, Engelmayr GC. Laser microfabricated poly(glycerol sebacate) scaffolds for heart valve tissue engineering. J Biomed Mater Res A 2013;101:104-14.
53. Miller JS, Shen CJ, Legant WR, Baranski JD, Blakely BL, Chen CS. Bioactive hydrogels made from step-growth derived PEG-peptide macromers. Biomaterials 2010;31:3736-43.
54. Schukur L, Zorlutuna P, Cha JM, Bae H, Khademhosseini A. Directed differentiation of size-controlled embryoid bodies towards endothelial and cardiac lineages in RGD-modified poly(ethylene glycol) hydrogels. Adv Healthc Mater 2013;2:195-205.
55. Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. J Cell Sci 2006;119:3901-3.
56. Lei Y, Rémy M, Labrugère C, Durrieu MC. Peptide immobilization on polyethylene terephthalate surfaces to study specific endothelial cell adhesion, spreading and migration. J Mater Sci Mater Med 2012;23:2761-72.
57. Patel D, Vandromme SE, Reid ME, Taite LJ. Synergistic activity of αvβ3 integrins and the elastin binding protein enhance cell-matrix interactions on bioactive hydrogel surfaces. Biomacromolecules 2012;13:1420-8.
58. Goubko CA, Majumdar S, Basak A, Cao X. Hydrogel cell patterning incorporating photocaged RGDS peptides. Biomed Microdevices 2010;12:555-68.
59. Xu FJ, Wang ZH, Yang WT. Surface functionalization of polycaprolactone films via surface-initiated atom transfer radical polymerization for covalently coupling cell-adhesive biomolecules. Biomaterials 2010;31:3139-47.
60. Sainger R, Grau JB, Branchetti E, Poggio P, Seefried WF, Field BC, et al. Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation. J Cell Physiol 2012;227:2595-604.
61. Durbin AD, Gotlieb AI. Advances towards understanding heart valve response to injury. Cardiovasc Pathol 2002;11:69-77.
62. Stephens EH, Shangkuan J, Kuo JJ, Carroll JL, Kearney DL, Carberry KE, et al. Extracellular matrix remodeling and cell phenotypic changes in dysplastic and hemodynamically altered semilunar human cardiac valves. Cardiovasc Pathol 2011;20:e157-67.
63. Xu S, Liu AC, Kim H, Gotlieb AI. Cell density regulates in vitro activation of heart valve interstitial cells. Cardiovasc Pathol 2012;21:65-73.
64. Cushing MC, Liao JT, Anseth KS. Activation of valvular interstitial cells is mediated by transforming growth factor-beta1 interactions with matrix molecules. Matrix Biol 2005;24:428-37.
65. Gould ST, Darling NJ, Anseth KS. Small peptide functionalized thiol-ene hydrogels as culture substrates for understanding valvular interstitial cell activation and de novo tissue deposition. Acta Biomater 2012;8:3201-9.
66. Quinlan AM, Billiar KL. Investigating the role of substrate stiffness in the persistence of valvular interstitial cell activation. J Biomed Mater Res A 2012;100:2474-82.
67. Stephens EH, Durst CA, West JL, Grande-Allen KJ. Mitral valvular interstitial cell responses to substrate stiffness depend on age and anatomic region. Acta Biomater 2011;7:75-82.